Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.

Molecular cancer therapeutics - 1 Jun 2008

Wallach-Dayan Shulamit Batya, Rubinstein Ariel M, Hand Carla, Breuer Raphael, Naor David

Abstract excerpt

We have shown recently that cDNA vaccination, using a virtual lymph node, ameliorates experimental allergic encephalomyelitis. Successful cure from mammary tumor requires resolution of local tumor growth and metastases. We have examined whether targeting of CD44 cell surface adhesion molecule by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neoplasm
Share to Clone Cells
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyaluronan Receptors

Share to Lymph Nodes

Share to Mammary Neoplasms, Experimental

Share to Vaccination

Share to Vaccines, DNA

Source

Identifiers

PMID: 18566232
DOI: 10.1158/1535-7163.MCT-07-2383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18566232-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.PMID 18566232Read ↗

CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.Semantic proximity Read ↗

Participation in normal immune responses of a metastasis-inducing splice variant of CD44.Semantic proximity Read ↗

Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune EvasionSemantic proximity Read ↗

Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.Semantic proximity Read ↗

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapySemantic proximity Read ↗

Modeling the specific CD4+ T cell response against a tumor neoantigen.Semantic proximity Read ↗

Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein.Semantic proximity Read ↗

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.Semantic proximity Read ↗

Vaccine of engineered tumor cells secreting stromal cell-derived factor-1 induces T-cell dependent antitumor responses.Semantic proximity Read ↗

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.Semantic proximity Read ↗

CD44 variant isoform v10 is expressed on tumor-infiltrating lymphocytes and mediates hyaluronan-independent heterotypic cell-cell adhesion to melanoma cells.Semantic proximity Read ↗

Annexin VII as a novel marker for invasive phenotype of malignant melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.